menu
Chinese Biopharmaceutical Contract Manufacturing Market is estimated to be worth USD 2.6 billion in 2030
The Growing Biopharma Industry in China has resulted in the creation of lucrative business opportunities for contract service providers; region-specific advantages have also attracted several foreign sponsors entities over the last few years

RootsAnalysis is pleased to announce the publication of its recent study, titled, “China Biopharmaceutical ContractManufacturing Market,2021-2030.”

Owingto benefits, such as reduced manufacturing costs, availability of cheap andskilled labor, and a supportive regulatory landscape, biopharmaceuticaldevelopers from across the globe, are increasingly outsourcing theirmanufacturing operations to China based CMOs. Further, in order to meet thegrowing demand for their services, Chinese CMOs are actively consolidating /expanding their capabilities through partnerships and / or dedicated expansioninitiatives.

ReadMore: https://www.rootsanalysis.com/reports/view_document/china-biopharmaceutical-contract-manufacturing/313.html

Thereport features an extensive study of the current market landscape and futureopportunities associated with the contract manufacturing of biopharmaceuticalsin China. The study also features a detailed analysis of key drivers and trendsrelated to this evolving domain. In addition to other elements, the studyincludes:

·       A detailed assessment of the current marketlandscape of companies offering contract manufacturing services forbiopharmaceuticals in China.

·       An analysis of the partnerships that havebeen established in this domain, in the recent past.

·       An analysis of the expansion initiativesundertaken by contract manufacturers in China, in order to augment theircapabilities, in the recent past.

·       A detailed analysis of more than 1500clinical trials related to biopharmaceuticals that have been / are being / arelikely to be conducted in China.

·       An estimate of the overall, installedcapacity for manufacturing biopharmaceuticals, based on data reported byindustry stakeholders in the public domain.

·       An analysis of the initiatives of bigbiopharma players engaged in this domain.

·       A qualitative analysis, highlighting thevarious factors that need to be taken into consideration by drug / therapydevelopers while deciding whether to manufacture their respective productsin-house or engage the services of a CMO.

·       Detailed profiles of key players that have adiverse range of capabilities for the development, manufacturing, and packagingof biopharmaceutical products.

·       A case study comparing the keycharacteristics of large molecule and small molecule drugs.

·       A discussion on industry affiliated trends,key drivers, and challenges, under a SWOT framework, which are likely to impactthe evolution of this field.

Adetailed market forecast, featuring analysis of the current and projectedfuture opportunity across key market segments (listed below)

Askfor PDF Sample @ BiopharmaceuticalContract Manufacturing Market Size

Typeof Product

·       API

·       FDF

Typeof Expression System Used

·       Mammalian

·       Microbial

·       Others

Scaleof Operation

·       Preclinical / Clinical

·       Commercial

Sizeof Manufacturer

·       Small

·       Mid-sized

·       Large / Very Large

Typeof Biologic

·       Antibody

·       Vaccine

·       Others

Keycompanies covered in the report

·       ChemPartner Biologics

·       JHL Biotech

·       JOINN Biologics

·       MabPlex

·       Mycenax Biotech

·       WuXi AppTec

Tableof Contents

1. Preface

2. Executive Summary

3. Introduction

4. Case Study: Comparison of Small Molecules and LargeMolecules

5. Competitive Landscape

6. Company Profiles

7. Partnerships

8. Recent Expansions

9. Clinical Trial Analysis

10. Regional Capability Analysis

11. Capacity Analysis

12. Big Pharma Biopharmaceutical ManufacturingInitiatives in China

13. Make Versus Buy Decision Making Framework

14. Market Sizing and Opportunity Analysis

15. COVID-19 Impact on China Biopharmaceutical CMO Market

16. SWOT Analysis

17. Future of the China Biopharmaceutical CMO Market

18. Interview Transcripts

19. APPENDIX 1: TABULATED DATA

20. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

Get CustomizeReport @ ChinaBiopharmaceutical Contract Manufacturing Market Trends and Analysis

AlsoVisit Our Latest Publication

Human Microbiome Market

In Silico / Computer-Aided DrugDiscovery Services Market

Antibody Contract Manufacturing Market

Biopharma Contract Manufacturing Market

Cell Therapy Manufacturing Market

AboutRoots Analysis

RootsAnalysis is one of the fastest growing marketresearch companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years ofsignificant experience in this sector. If you’d like help with your growingbusiness needs, get in touch at info@rootsanalysis.com

ContactInformation

RootsAnalysis Private Limited

GauravChaudhary

+1(415) 800 3415

Gaurav.Chaudhary@rootsanalysis.com